PDT agents currently used in the clinic operate primarily through the oxygen-dependent Type II mechanism, meaning that these agents are largely ineffective in hypoxic environments. Recently, we and others found that a lysosome-targeted photosensitizer, EtNBS, specifically accumulated into otherwise therape...